Zealand Pharma Appoints Henriette Wennicke as Chief Financial Officer
Provided By Globe Newswire
Last update: Aug 24, 2022
COMPANY ANNOUNCEMENT – NO. 36 / 2022
Copenhagen, DK and Boston, MA, August 24, 2022 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced the appointment of Henriette Wennicke as Zealand’s Chief Financial Officer starting November 1, 2022.
